Music |
Video |
Movies |
Chart |
Show |
Michael Morris, MD Discusses the Future of PSMA-Targeted Therapies in APC - Part 1 (DocWire) View | |
Michael Morris, MD Discusses the Future of PSMA-Targeted Therapies in APC - Part 2 (DocWire) View | |
VISION trial supports LuPSMA-targeting therapy for mCRPC | Michael Morris (Medicine Matters oncology) View | |
Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prosta... (ecancer) View | |
ASCO Daily News 2021 Plenary Update - LBA4: VISION (ASCOcancer) View | |
Limitations of Lutetium-177-PSMA u0026 Addressing Treatment Challenges (DocWire) View | |
10/3/2019 - Session 1: Michael J. Morris, MD (NASEM Health and Medicine Division) View | |
2017 MSK Alumni Conference - Michael J. Morris, MD (Memorial Sloan Kettering Alumni Society) View | |
Fernando Acosta's Testimonial with Lutetium-177 PSMA Radioligand Therapy. (Oncidium foundation) View | |
5th Annual Jimmy Sayegh Game Dr. Michael Morris Speech (Ivan Marquez) View |